Evaluate Performance of Callisto Eye vs. Wavetec AnalyzOR - Trial NCT06216067
Access comprehensive clinical trial information for NCT06216067 through Pure Global AI's free database. This phase not specified trial is sponsored by Chesapeake Eyecare and Laser Center, LLC and is currently Completed. The study focuses on Cataract. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chesapeake Eyecare and Laser Center, LLC
Timeline & Enrollment
N/A
Dec 14, 2021
Jul 21, 2023
Primary Outcome
Diopters of Residual Cylinder
Summary
The goal of this clinical trial is to evaluate two separate operating room cataract measuring
 tools in predicting the residual astigmatism (prediction error) in patients with corneal
 astigmatism.
 
 The main question it aims to answer is:
 
 Show the refractive predictability comparing the use of Operating Room cataract toric lens
 placement tools against the standard manual technique.
 
 Participants will be implanted with the TECNIS Toric II IOL Lens Model ZCU; the second eye,
 if applicable, is to be implanted within 45 days of the first-eye surgery.
 
 Researchers will compare two Operating Room cataract lens placement tools: the Zeiss CALLISTO
 vs. the Wavetec AnalyzOR to determine refractive predictability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06216067
Device Trial